1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Anti-Inflammatory Therapeutics Market
2.3. Global Anti-Inflammatory Therapeutics Market, By Drug, 2025 (US$ Million)
2.4. Global Anti-Inflammatory Therapeutics Market, By Indication, 2025 (US$ Million)
2.5. Global Anti-Inflammatory Therapeutics Market, By Geography, 2025 (US$ Million)
2.6. Attractive Investment Proposition by Geography, 2025
3. Anti-Inflammatory Therapeutics Market: Competitive Analysis
3.1. Market Positioning of Key Anti-Inflammatory Therapeutics Market Vendors
3.2. Strategies Adopted by Anti-Inflammatory Therapeutics Market Vendors
4. Anti-Inflammatory Therapeutics Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Anti-Inflammatory Therapeutics Market Value, 2024 - 2034, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. Porter's Five Force Model
4.5.1. Supplier Power
4.5.2. Buyer Power
4.5.3. Threat Of Substitutes
4.5.4. Threat Of New Entrants
4.5.5. Competitive Rivalry
4.6. PESTEL Analysis
4.6.1. Political Landscape
4.6.2. Economic Landscape
4.6.3. Social Landscape
4.6.4. Technology Landscape
4.6.5. Environmental Landscape
4.6.6. Legal Landscape
5. Anti-Inflammatory Therapeutics Market: By Drug, 2024-2034, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2025 Versus 2034
5.3. Market Segmentation
5.3.1. Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
5.3.2. Corticosteroids
5.3.3. Biologics
5.3.4. Immune Selective Anti-inflammatory Derivatives (ImSAIDs)
6. Anti-Inflammatory Therapeutics Market: By Indication, 2024-2034, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2025 Versus 2034
6.3. Market Segmentation
6.3.1. Rheumatoid Arthritis
6.3.2. Chronic obstructive pulmonary disease (COPD)
6.3.3. Multiple Sclerosis
6.3.4. Inflammatory bowel disease (IBD)
6.3.5. Psoriatic Arthritis
6.3.6. Gout
6.3.7. Others (Osteoarthritis, Systemic lupus, Psoriasis)
7. North America Anti-Inflammatory Therapeutics Market, 2024-2034, USD (Million)
7.1. Market Overview
7.2. Anti-Inflammatory Therapeutics Market: By Drug, 2024-2034, USD (Million)
7.3. Anti-Inflammatory Therapeutics Market: By Indication, 2024-2034, USD (Million)
7.4. Anti-Inflammatory Therapeutics Market: By Region, 2024-2034, USD (Million)
7.4.1.North America
7.4.1.1. U.S.
7.4.1.1.1. Anti-Inflammatory Therapeutics Market: By Drug, 2024-2034, USD (Million)
7.4.1.1.2. Anti-Inflammatory Therapeutics Market: By Indication, 2024-2034, USD (Million)
7.4.1.2. Canada
7.4.1.2.1. Anti-Inflammatory Therapeutics Market: By Drug, 2024-2034, USD (Million)
7.4.1.2.2. Anti-Inflammatory Therapeutics Market: By Indication, 2024-2034, USD (Million)
7.4.1.3. Rest of North America
7.4.1.3.1. Anti-Inflammatory Therapeutics Market: By Drug, 2024-2034, USD (Million)
7.4.1.3.2. Anti-Inflammatory Therapeutics Market: By Indication, 2024-2034, USD (Million)
8. UK and European Union Anti-Inflammatory Therapeutics Market, 2024-2034, USD (Million)
8.1. Market Overview
8.2. Anti-Inflammatory Therapeutics Market: By Drug, 2024-2034, USD (Million)
8.3. Anti-Inflammatory Therapeutics Market: By Indication, 2024-2034, USD (Million)
8.4. Anti-Inflammatory Therapeutics Market: By Region, 2024-2034, USD (Million)
8.4.1.UK and European Union
8.4.1.1. UK
8.4.1.1.1. Anti-Inflammatory Therapeutics Market: By Drug, 2024-2034, USD (Million)
8.4.1.1.2. Anti-Inflammatory Therapeutics Market: By Indication, 2024-2034, USD (Million)
8.4.1.2. Germany
8.4.1.2.1. Anti-Inflammatory Therapeutics Market: By Drug, 2024-2034, USD (Million)
8.4.1.2.2. Anti-Inflammatory Therapeutics Market: By Indication, 2024-2034, USD (Million)
8.4.1.3. Spain
8.4.1.3.1. Anti-Inflammatory Therapeutics Market: By Drug, 2024-2034, USD (Million)
8.4.1.3.2. Anti-Inflammatory Therapeutics Market: By Indication, 2024-2034, USD (Million)
8.4.1.4. Italy
8.4.1.4.1. Anti-Inflammatory Therapeutics Market: By Drug, 2024-2034, USD (Million)
8.4.1.4.2. Anti-Inflammatory Therapeutics Market: By Indication, 2024-2034, USD (Million)
8.4.1.5. France
8.4.1.5.1. Anti-Inflammatory Therapeutics Market: By Drug, 2024-2034, USD (Million)
8.4.1.5.2. Anti-Inflammatory Therapeutics Market: By Indication, 2024-2034, USD (Million)
8.4.1.6. Rest of Europe
8.4.1.6.1. Anti-Inflammatory Therapeutics Market: By Drug, 2024-2034, USD (Million)
8.4.1.6.2. Anti-Inflammatory Therapeutics Market: By Indication, 2024-2034, USD (Million)
9. Asia Pacific Anti-Inflammatory Therapeutics Market, 2024-2034, USD (Million)
9.1. Market Overview
9.2. Anti-Inflammatory Therapeutics Market: By Drug, 2024-2034, USD (Million)
9.3. Anti-Inflammatory Therapeutics Market: By Indication, 2024-2034, USD (Million)
9.4. Anti-Inflammatory Therapeutics Market: By Region, 2024-2034, USD (Million)
9.4.1.Asia Pacific
9.4.1.1. China
9.4.1.1.1. Anti-Inflammatory Therapeutics Market: By Drug, 2024-2034, USD (Million)
9.4.1.1.2. Anti-Inflammatory Therapeutics Market: By Indication, 2024-2034, USD (Million)
9.4.1.2. Japan
9.4.1.2.1. Anti-Inflammatory Therapeutics Market: By Drug, 2024-2034, USD (Million)
9.4.1.2.2. Anti-Inflammatory Therapeutics Market: By Indication, 2024-2034, USD (Million)
9.4.1.3. India
9.4.1.3.1. Anti-Inflammatory Therapeutics Market: By Drug, 2024-2034, USD (Million)
9.4.1.3.2. Anti-Inflammatory Therapeutics Market: By Indication, 2024-2034, USD (Million)
9.4.1.4. Australia
9.4.1.4.1. Anti-Inflammatory Therapeutics Market: By Drug, 2024-2034, USD (Million)
9.4.1.4.2. Anti-Inflammatory Therapeutics Market: By Indication, 2024-2034, USD (Million)
9.4.1.5. South Korea
9.4.1.5.1. Anti-Inflammatory Therapeutics Market: By Drug, 2024-2034, USD (Million)
9.4.1.5.2. Anti-Inflammatory Therapeutics Market: By Indication, 2024-2034, USD (Million)
9.4.1.6. Rest of Asia Pacific
9.4.1.6.1. Anti-Inflammatory Therapeutics Market: By Drug, 2024-2034, USD (Million)
9.4.1.6.2. Anti-Inflammatory Therapeutics Market: By Indication, 2024-2034, USD (Million)
10. Latin America Anti-Inflammatory Therapeutics Market, 2024-2034, USD (Million)
10.1. Market Overview
10.2. Anti-Inflammatory Therapeutics Market: By Drug, 2024-2034, USD (Million)
10.3. Anti-Inflammatory Therapeutics Market: By Indication, 2024-2034, USD (Million)
10.4. Anti-Inflammatory Therapeutics Market: By Region, 2024-2034, USD (Million)
10.4.1.Latin America
10.4.1.1. Brazil
10.4.1.1.1. Anti-Inflammatory Therapeutics Market: By Drug, 2024-2034, USD (Million)
10.4.1.1.2. Anti-Inflammatory Therapeutics Market: By Indication, 2024-2034, USD (Million)
10.4.1.2. Mexico
10.4.1.2.1. Anti-Inflammatory Therapeutics Market: By Drug, 2024-2034, USD (Million)
10.4.1.2.2. Anti-Inflammatory Therapeutics Market: By Indication, 2024-2034, USD (Million)
10.4.1.3. Rest of Latin America
10.4.1.3.1. Anti-Inflammatory Therapeutics Market: By Drug, 2024-2034, USD (Million)
10.4.1.3.2. Anti-Inflammatory Therapeutics Market: By Indication, 2024-2034, USD (Million)
11. Middle East and Africa Anti-Inflammatory Therapeutics Market, 2024-2034, USD (Million)
11.1. Market Overview
11.2. Anti-Inflammatory Therapeutics Market: By Drug, 2024-2034, USD (Million)
11.3. Anti-Inflammatory Therapeutics Market: By Indication, 2024-2034, USD (Million)
11.4. Anti-Inflammatory Therapeutics Market: By Region, 2024-2034, USD (Million)
11.4.1.Middle East and Africa
11.4.1.1. GCC
11.4.1.1.1. Anti-Inflammatory Therapeutics Market: By Drug, 2024-2034, USD (Million)
11.4.1.1.2. Anti-Inflammatory Therapeutics Market: By Indication, 2024-2034, USD (Million)
11.4.1.2. Africa
11.4.1.2.1. Anti-Inflammatory Therapeutics Market: By Drug, 2024-2034, USD (Million)
11.4.1.2.2. Anti-Inflammatory Therapeutics Market: By Indication, 2024-2034, USD (Million)
11.4.1.3. Rest of Middle East and Africa
11.4.1.3.1. Anti-Inflammatory Therapeutics Market: By Drug, 2024-2034, USD (Million)
11.4.1.3.2. Anti-Inflammatory Therapeutics Market: By Indication, 2024-2034, USD (Million)
12. Company Profile
12.1. Pfizer, Inc. (Company Overview, Financial Performance, Product Portfolio, Strategic Initiatives)
12.2. Amgen, Inc.
12.3. AstraZeneca plc
12.4. Eli Lily and Company
12.5. GlaxoSmithKline plc
12.6. Johnson & Johnson
12.7. Merck & Company, Inc.
12.8. Novartis International AG
12.9. AbbVie Inc
12.10. F. Hoffmann-La Roche AG
